Amin Pharmaceutical Co (XTEH:AMIN1) Purchase Of Business : IRR Mil (TTM As of . 20)

View and export this data going back to 1990. Start your Free Trial

What is Amin Pharmaceutical Co Purchase Of Business?

Amin Pharmaceutical Co's purchase of business for the six months ended in . 20 was IRR0.00 Mil. It means Amin Pharmaceutical Co spent IRR0.00 Mil on purchasing business.

Compared with last quarter (IRR0.00 Mil in . 20 ), Amin Pharmaceutical Co spent the same money on purchasing business in . 20 (IRR0.00 Mil).

Amin Pharmaceutical Co Purchase Of Business Historical Data

The historical data trend for Amin Pharmaceutical Co's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amin Pharmaceutical Co Purchase Of Business Chart

Amin Pharmaceutical Co Annual Data

Trend

Purchase Of Business

Amin Pharmaceutical Co Semi-Annual Data

Purchase Of Business

Amin Pharmaceutical Co Purchase Of Business Calculation

The amount used to purchase business.

Amin Pharmaceutical Co Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Amin Pharmaceutical Co's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Amin Pharmaceutical Co (XTEH:AMIN1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amin Pharmaceutical Co (XTEH:AMIN1) » Definitions » Purchase Of Business

Comparable Companies

Traded in Other Exchanges

N/A

Address

Abolfazl Street, Bostan Heftam West Alley, No. 4, 2nd floor, Marzdaran, Tehran, IRN

Website

https://www.aminpharma.com

Amin Pharmaceutical Co is engaged in the manufacturing of pharmaceutical products, chemical drugs, herbal medicines, and nutritional supplements. It offers antimicrobials, cardiovascular, antidiabetic, cerebellar, gastrointestinal, antibiotic and antifungal, and hypoglycemic agents among others. It develops drugs in the form of plain and overlaid tablets, hard, and soft capsules, oral drops, syrups, and suspensions. Products offered by the company include Acarbose, Sitagliptin, Fampridine, Ofloxacin, Amiodarone, Ibuprofen, Zolpidem, Bilberry, Thyme, and others. Amin also exports its products to Afghanistan, Kazakhstan, Uzbekistan, and Iraq.

Amin Pharmaceutical Co (XTEH:AMIN1) Headlines

No Headlines